Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/30103
Title: | Oncogenic Signaling Pathways in The Cancer Genome Atlas |
Authors: | SANCHEZ-VEGA, Francisco; MINA, Marco; ARMENIA, Joshua; CHATILA, Walid K.; LUNA, Augustin; LA, Konnor C.; DIMITRIADOY, Sofia; LIU, David L.; KANTHETI, Havish S.; SAGHAFINIA, Sadegh; CHAKRAVARTY, Debyani; DAIAN, Foysal; GAO, Qingsong; BAILEY, Matthew H.; LIANG, Wen-Wei; FOLTZ, Steven M.; SHMULEVICH, Ilya; DING, Li; HEINS, Zachary; OCHOA, Angelica; GROSS, Benjamin; GAO, Jianjiong; ZHANG, Hongxin; KUNDRA, Ritika; KANDOTH, Cyriac; BAHCECI, Istemi; DERVISHI, Leonard; DOGRUSOZ, Ugur; ZHOU, Wanding; SHEN, Hui; LAIRD, Peter W.; WAY, Gregory P.; GREENE, Casey S.; LIANG, Han; XIAO, Yonghong; WANG, Chen; IAVARONE, Antonio; BERGER, Alice H.; BIVONA, Trever G.; LAZAR, Alexander J.; HAMMER, Gary D.; GIORDANO, Thomas; KWONG, Lawrence N.; MCARTHUR, Grant; HUANG, Chenfei; TWARD, Aaron D.; FREDERICK, Mitchell J.; MCCORMICK, Frank; MEYERSON, Matthew; ALLEN, Eliezer M. Van; CHERNIACK, Andrew D.; CIRIELLO, Giovanni; SANDER, Chris; SCHULTZ, Nikolaus |
Citation: | CELL, v.173, n.2, p.321-337.e10, 2018 |
Abstract: | Genetic alterations in signaling pathways that control cell-cycle progression, apoptosis, and cell growth are common hallmarks of cancer, but the extent, mechanisms, and co-occurrence of alterations in these pathways differ between individual tumors and tumor types. Using mutations, copy-number changes, mRNA expression, gene fusions and DNA methylation in 9,125 tumors profiled by The Cancer Genome Atlas (TCGA), we analyzed the mechanisms and patterns of somatic alterations in ten canonical pathways: cell cycle, Hippo, Myc, Notch, Nrf2, PI-3-Kinase/Akt, RTK-RAS, TGFb signaling, p53 and beta-catenin/Wnt. We charted the detailed landscape of pathway alterations in 33 cancer types, stratified into 64 subtypes, and identified patterns of co-occurrence and mutual exclusivity. Eighty-nine percent of tumors had at least one driver alteration in these one alteration potentially targetable by currently available drugs. Thirty percent of tumors had multiple targetable alterations, indicating opportunities for combination therapy. |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - FM/Outros Artigos e Materiais de Revistas Científicas - IMT Artigos e Materiais de Revistas Científicas - LIM/14 Artigos e Materiais de Revistas Científicas - ODS/03 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_SANCHEZ-VEGA_Oncogenic_Signaling_Pathways_in_The_Cancer_Genome_Atlas_2018.PDF | publishedVersion (English) | 3.07 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.